
Sign up to save your podcasts
Or


John McMillen and Bill Wolfe discuss the pharmacy industry's ongoing consolidation, focusing on its impact on various stakeholders. Bill Wolfe shares his experience in the industry, highlighting the efficiency and value of the Pharmacist and pharmacy benefit. John McMillen emphasizes the importance of understanding each deal's nuances and possible implications for the broader ecosystem. Later, John McMillen and Bill Wolfe discuss the need to shift the pharmacy practice focus from cost and rebates to efficiency and patient outcomes and the importance of patient engagement and adherence to medication regimens. Bill highlights the need to address high drug costs and promote transparency in pricing. Finally, John McMillen and Bill Wolf advocate recognizing pharmacists as providers and empowering pharmacy technicians to take on more responsibilities.
Start: Expand the definition of "provider" to include pharmacists in more states. Allow pharmacy technicians to take on expanded roles with appropriate training.
Stop: shift the pharmacy practice focus from cost and rebates to efficiency, patient outcomes, and patient engagement and adherence to medication regimens.
Continue: Encourage patients to use digital tools like medical memory to improve medication adherence and engagement. Continue advocating for pharmacists' provider status and reimbursement models that recognize their value.
By Julie SoukupJohn McMillen and Bill Wolfe discuss the pharmacy industry's ongoing consolidation, focusing on its impact on various stakeholders. Bill Wolfe shares his experience in the industry, highlighting the efficiency and value of the Pharmacist and pharmacy benefit. John McMillen emphasizes the importance of understanding each deal's nuances and possible implications for the broader ecosystem. Later, John McMillen and Bill Wolfe discuss the need to shift the pharmacy practice focus from cost and rebates to efficiency and patient outcomes and the importance of patient engagement and adherence to medication regimens. Bill highlights the need to address high drug costs and promote transparency in pricing. Finally, John McMillen and Bill Wolf advocate recognizing pharmacists as providers and empowering pharmacy technicians to take on more responsibilities.
Start: Expand the definition of "provider" to include pharmacists in more states. Allow pharmacy technicians to take on expanded roles with appropriate training.
Stop: shift the pharmacy practice focus from cost and rebates to efficiency, patient outcomes, and patient engagement and adherence to medication regimens.
Continue: Encourage patients to use digital tools like medical memory to improve medication adherence and engagement. Continue advocating for pharmacists' provider status and reimbursement models that recognize their value.